IL255076B2
Bispecific antibody constructs for cdh3 and cd3
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO2006114704A2 | Cites | World Intellectual Property Organization (WIPO) | Y | Search report | 4-11 |
| WO2007102525A1 | Cites | World Intellectual Property Organization (WIPO) | – | Search report | – |
| WO2008119567A2 | Cites | World Intellectual Property Organization (WIPO) | Y | Search report | 17 |
| WO2010001585A1 | Cites | World Intellectual Property Organization (WIPO) | XY | Search report | 1-16,18-32 |
| WO2012057315A1 | Cites | World Intellectual Property Organization (WIPO) | Y | Search report | 4-11 |
| WO2012145183A2 | Cites | World Intellectual Property Organization (WIPO) | – | Search report | – |
| US2014221620A1 | Cites | United States of America | – | Search report | – |
| WO2016001810A1 | Cites | World Intellectual Property Organization (WIPO) | X | Search report | 20 |
| EP2426149A1 | Cites | European Patent Office (EPO) | – | Search report | – |
44 members in 25 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 15164154 | European Patent Office (EPO) | A | |
| 151641545 | European Patent Office (EPO) | – | |
| 2016058482 | European Patent Office (EPO) | W |
Members44
| Document | Office | Kind | |
|---|---|---|---|
| CA2982682A1 | Canada | A1 | |
| WO2016166360A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW201704264A | Taiwan Province of China | A | |
| AR104309A1 | Argentina | A1 | |
| AU2016250023A1 | Australia | A1 | |
| SG11201708438WA | Singapore | A | |
| IL255076A0 | Israel | A0 | |
| IL255076D0 | Israel | D0 | |
| EP3283524A1 | European Patent Office (EPO) | A1 | |
| CN107750255A | China | A | |
| KR20180023892A | Republic of Korea | A | |
| CL2017002641A1 | Chile | A1 | |
| JP2018512860A | Japan | A | |
| US2018142021A1 | United States of America | A1 | |
| EA201792193A1 | Eurasian Patent Organization (EAPO) | A1 | |
| BR112017022326A2 | Brazil | A2 | |
| MX2017013348A | Mexico | A | |
| MA43197A | Morocco | A | |
| SG10201909308XA | Singapore | A | |
| US11028171B2 | United States of America | B2 | |
| JP6907124B2 | Japan | B2 | |
| AU2016250023B2 | Australia | B2 | |
| AU2022203450A1 | Australia | A1 | |
| TWI772258B | Taiwan Province of China | B | |
| CN107750255B | China | B | |
| US2023041876A1 | United States of America | A1 | |
| TW202311292A | Taiwan Province of China | A | |
| EP3283524B1 | European Patent Office (EPO) | B1 | |
| CN116063541A | China | A | |
| FI3283524T3 | Finland | T3 | |
| LT3283524T | Lithuania | T | |
| DK3283524T3 | Denmark | T3 | |
| IL255076B1 | Israel | B1 | |
| PT3283524T | Portugal | T | |
| PL3283524T3 | Poland | T3 | |
| ES2945313T3 | Spain | T3 | |
| SI3283524T1 | Slovenia | T1 | |
| HUE061730T2 | Hungary | T2 | |
| IL255076B2This record | Israel | B2 | |
| EP4276116A2 | European Patent Office (EPO) | A2 | |
| EP4276116A3 | European Patent Office (EPO) | A3 | |
| US11926666B2 | United States of America | B2 | |
| TWI858372B | Taiwan Province of China | B | |
| US2025092133A1 | United States of America | A1 |
Numbers
- Publication
- 255076
- Application
- 255076
Titles2
- English
- BISPECIFIC ANTIBODY CONSTRUCTS FOR CDH3 AND CD3
- Hebrew
- קונסטרוקטים של נוגדנים בי-ספציפיים ל- CDH3 ו- CD3
Classification
- CPC, 15
- C07K16/28
- C07K16/2809
- A61K2039/505
- A61P35/00
- C07K2317/622
- C07K2317/73
- C07K2317/92
- C07K16/3053
- C07K2317/31
- C07K2317/33
- C07K2317/56
- C07K2317/565
- A61P35/02
- C07K2317/94
- C07K2317/732
- IPC, 4
- A61K39 00
- C07K16 28
- C07K16 30
- A61P35 00